PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.07%
Both yoy net incomes decline, with AVGO at -18.83%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-0.90%
Both reduce yoy D&A, with AVGO at -5.13%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
96.36%
Well above AVGO's 23.13% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
4.55%
SBC growth of 4.55% while AVGO is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-149.76%
Both reduce yoy usage, with AVGO at -300.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-73.31%
AR is negative yoy while AVGO is 146.51%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-144.83%
Both reduce yoy inventory, with AVGO at -83.33%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
54.88%
A yoy AP increase while AVGO is negative at -134.78%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-323.08%
Both reduce yoy usage, with AVGO at -1080.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
100.00%
Some yoy increase while AVGO is negative at -21.88%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-53.76%
Both yoy CFO lines are negative, with AVGO at -28.72%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
32.68%
Some CapEx rise while AVGO is negative at -27.03%. John Neff would see competitor possibly building capacity while we hold back expansions.
-1660.00%
Negative yoy acquisition while AVGO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
79.61%
Purchases growth of 79.61% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
60.84%
Liquidation growth of 60.84% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
127.08%
We have mild expansions while AVGO is negative at -23.68%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-50.00%
We cut debt repayment yoy while AVGO is 100.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
103.94%
We slightly raise equity while AVGO is negative at -66.67%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.